MRCEM Primary revision is a core part of UK Emergency Medicine practice. Immunology sits squarely within the pathology and physiology domains of the MRCEM Primary syllabus, and questions on adaptive immunity appear with reliable frequency. Beyond the examination, understanding primary and secondary immune responses is clinically essential in the Emergency Department: it underpins the pathophysiology of anaphylaxis, explains why immunocompromised patients present atypically, informs the rationale for booster vaccinations, and contextualises post-infectious complications such as rheumatic fever or glomerulonephritis. Mastery of the cellular mechanisms, antibody kinetics, and clinical correlates covered here will serve you both in the MRCEM Primary exam and at the bedside.
Key Points: Primary and Secondary Immune Responses
- The primary immune response takes 10 to 14 days to peak and is dominated by IgM, reflecting naive lymphocyte activation and clonal expansion from first antigen encounter.
- The secondary (anamnestic) response is faster (1 to 3 days), larger in magnitude, longer in duration, and predominantly IgG, owing to pre-existing memory B and T cells.
- Co-stimulatory signals (CD80/86 on the antigen-presenting cell binding CD28 on the T cell) are mandatory for full T-cell activation; their absence induces clonal anergy.
- Somatic hypermutation and affinity maturation in germinal centres underpin the higher-affinity antibodies characteristic of the secondary response.
- Anaphylaxis represents a pathological secondary immune response: IgE bound to mast cells cross-links on re-exposure, triggering immediate mediator release.
- The MRCEM Primary exam tests kinetics, cell types, immunoglobulin classes, and clinical scenarios including vaccine schedules and immunodeficiency states.
Adaptive Immunity: Definition and Clinical Context
The adaptive immune system is defined by three cardinal properties: antigen specificity, diversity, and immunological memory. It operates alongside, and in concert with, the innate immune system, but it is the adaptive response that determines long-term protection against re-infection and underpins the efficacy of vaccines. Two principal lymphocyte lineages execute adaptive immunity: T lymphocytes, which mediate cell-mediated immunity, and B lymphocytes, which mediate humoral immunity via antibody secretion. Both originate from haematopoietic stem cells in the bone marrow. T cells migrate to the thymus for positive and negative selection; B cells complete maturation in the bone marrow itself before trafficking to secondary lymphoid organs, principally the lymph nodes and spleen.
In the ED, the clinical consequences of adaptive immunity are encountered daily. The patient with anaphylaxis to penicillin has experienced a pathological secondary response. The asplenic patient attending with overwhelming pneumococcal sepsis has lost a critical secondary lymphoid organ. The child presenting with a second episode of varicella has either an incomplete primary response or, more likely, an acquired immunodeficiency. NICE guidance on immunisation and infection management reinforces that clinicians must understand these mechanisms to interpret vaccine schedules and manage immunocompromised presentations rationally.
The Primary Immune Response: Mechanism and Kinetics
On first encounter with a novel antigen, the adaptive immune system must build its response from scratch using naive, antigen-inexperienced lymphocytes. This process is inherently slow because clonal selection, activation, and proliferation must all occur before effector function is possible.
Sequence of Events
Antigen enters the body and is captured by professional antigen-presenting cells (APCs), principally dendritic cells, which are strategically located at mucosal surfaces and skin. Dendritic cells process the antigen into peptide fragments and load them onto major histocompatibility complex (MHC) class II molecules for presentation to CD4+ T helper cells, or onto MHC class I molecules for CD8+ cytotoxic T cells. This distinction is important: endogenous antigens (e.g. viral proteins synthesised within a cell) are presented on MHC class I to CD8+ cells, while exogenous antigens (e.g. bacterial proteins taken up by phagocytosis) are presented on MHC class II to CD4+ cells.
Critically, T-cell activation requires two signals. Signal one is antigen recognition via the T-cell receptor binding the MHC-peptide complex. Signal two is a co-stimulatory interaction: CD80 or CD86 on the APC binds CD28 on the T cell. In the absence of this co-stimulatory signal, the T cell becomes anergic rather than activated. This two-signal requirement is a fail-safe mechanism that prevents autoimmune responses to self-antigens, which are presented without appropriate co-stimulation in peripheral tissues.
Once activated, CD4+ T helper cells secrete interleukin-2 (IL-2), which drives clonal expansion of both T and B cell populations. B cells receive additional T-cell help via CD40L (on the T cell) binding CD40 (on the B cell), a critical interaction for germinal centre formation. Within germinal centres of secondary lymphoid follicles, B cells undergo somatic hypermutation of their immunoglobulin variable regions and affinity maturation, selecting those clones with the highest antigen-binding affinity. Class switch recombination then changes the immunoglobulin heavy chain constant region, allowing production of IgG, IgA, or IgE in addition to the initial IgM.
The kinetics of the primary response reflect this complexity. Antibody is detectable after approximately 7 days, peaks at 10 to 14 days, and is predominantly IgM early, with IgG appearing later as class switching occurs. The overall titre is relatively modest. A subset of activated lymphocytes differentiates not into effector cells but into long-lived memory B and T cells, which persist in bone marrow niches and secondary lymphoid organs for years to decades.
The Secondary (Anamnestic) Immune Response
Re-exposure to the same antigen, whether through natural infection, vaccination booster, or allergen challenge, triggers the secondary immune response. Because memory B and T cells are already present in large numbers, are more readily activated (lower activation threshold, reduced co-stimulatory requirement), and are pre-committed to antigen-specific clones, the response is qualitatively and quantitatively superior to the primary response in almost every measurable parameter.
Antibody appears within 1 to 3 days of re-exposure. The peak titre is orders of magnitude higher than in the primary response. IgG predominates, and these antibodies are of higher affinity due to the affinity maturation that occurred during the primary response. IgG has a longer half-life than IgM, conferring more durable protection. The secondary response is also more prolonged, with antibody titres remaining elevated for weeks to months.
The clinical significance is substantial. Vaccine schedules exploit this biology deliberately: a primary course of vaccination (often two or three doses) generates memory; booster doses at defined intervals invoke the secondary response to raise titres to protective levels. The NHS immunisation schedule is designed around precisely this immunological framework, with primary courses in infancy followed by pre-school and adolescent boosters.
Comparison Table: Primary Versus Secondary Response
Lag phase: 7 to 14 days (primary) versus 1 to 3 days (secondary). Peak antibody titre: Low to moderate (primary) versus very high (secondary). Predominant antibody class: IgM then IgG (primary) versus IgG, with IgA or IgE depending on site and stimulus (secondary). Antibody affinity: Lower (primary) versus higher, due to affinity maturation (secondary). Duration: Weeks (primary) versus months to years (secondary). Cells responsible: Naive B and T cells (primary) versus memory B and T cells (secondary).
ED Clinical Correlates
These mechanisms are not abstract laboratory concepts. They manifest directly in ED presentations.
Anaphylaxis is the most clinically urgent secondary immune response. On first allergen exposure (e.g. latex, peanut, beta-lactam antibiotic), the primary response generates IgE, which binds to high-affinity Fc receptors on mast cells and basophils without causing symptoms. On re-exposure, the allergen cross-links IgE on mast cell surfaces, triggering immediate degranulation and release of histamine, tryptase, leukotrienes, and prostaglandins. The Resuscitation Council UK anaphylaxis guidelines outline the management algorithm, which every ED clinician must know. Elevated serum tryptase, measured at 1 to 2 hours post-event and again at 24 hours, confirms mast cell degranulation and supports the diagnosis.
Immunocompromised patients (whether secondary to HIV, haematological malignancy, immunosuppressive therapy, or asplenia) present atypically because both primary and secondary responses are impaired. They may lack the febrile response, fail to mount a leucocytosis, and present in extremis before standard clinical warning signs have emerged. Understanding the cellular basis of their immunodeficiency (T-cell depletion in HIV, B-cell dysfunction in common variable immunodeficiency, complement deficiency in encapsulated bacterial susceptibility) directs appropriate empirical antimicrobial therapy.
Post-infectious immune-mediated complications such as rheumatic fever following group A streptococcal pharyngitis, or post-streptococcal glomerulonephritis, are consequences of molecular mimicry and aberrant secondary immune responses where antibodies generated against bacterial antigens cross-react with host tissue.
How the MRCEM Primary Exam Tests This Topic
The MRCEM Primary exam, delivered as a single best answer (SBA) paper, tests immunology within the pathology domain of the RCEM curriculum. Candidates preparing with MRCEM Primary revision course at EM Learning Centre will encounter questions built around several recurring patterns.
Kinetics questions present a graph or data set and ask the candidate to identify which curve represents the primary or secondary response, or which immunoglobulin is predominant at a given time point. Knowing that IgM peaks first in the primary response and that IgG dominates the secondary response is non-negotiable.
Cell biology questions ask about the origin of specific cell types (e.g. where do plasma cells arise from, or which cell type presents antigen on MHC class II), the significance of CD4 versus CD8 T cells, and the role of co-stimulation. A common distractor is conflating MHC class I and class II presentation pathways.
Clinical scenario questions embed the immunology in an ED presentation: a child with a second anaphylactic reaction to nuts, a patient who fails to respond to vaccination, or a splenectomised patient with pneumococcal sepsis. The question stem will point to a specific immunological mechanism and ask the candidate to identify the underlying biology or most appropriate intervention.
Immunoglobulin class questions test which immunoglobulin is the first produced in a primary response (IgM), which crosses the placenta (IgG), which is secreted at mucosal surfaces (IgA), and which mediates type I hypersensitivity (IgE).
The RCEM curriculum maps this content under the basic sciences component, and candidates should cross-reference their revision with the published syllabus available via the Royal College of Emergency Medicine website.
Revision Pearls: High-Yield Facts for the MRCEM Primary Exam
- IgM is the first immunoglobulin produced in the primary response and is the most efficient activator of complement via the classical pathway.
- IgG is the only immunoglobulin that crosses the placenta, providing neonatal passive immunity for the first 3 to 6 months of life.
- The germinal centre is the site of somatic hypermutation, affinity maturation, and class switch recombination, all of which occur in secondary lymphoid organs (lymph nodes, spleen, Peyer’s patches).
- Clonal anergy results from antigen presentation without co-stimulation (signal one without signal two), a key peripheral tolerance mechanism.
- Memory B cells are long-lived, require less T-cell help for reactivation, and produce high-affinity IgG rapidly on antigen re-exposure.
- Serum tryptase elevated above 11.4 micrograms per litre supports the diagnosis of anaphylaxis and should be measured at 1 to 2 hours and repeated at 24 hours as per Resuscitation Council UK guidance.
- Asplenic patients are particularly susceptible to encapsulated organisms (Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis) because the spleen is a major site of opsonisation and B-cell activation against polysaccharide antigens.
- Type I hypersensitivity (immediate, IgE-mediated) is the mechanism of anaphylaxis, urticaria, and allergic asthma; it must be distinguished from type II (cytotoxic, IgG/IgM), type III (immune complex), and type IV (delayed, T-cell-mediated) reactions in examination questions.
Common Pitfalls: Where Candidates Lose Marks
- Confusing MHC class I (presents to CD8+ cytotoxic T cells, expressed on all nucleated cells) with MHC class II (presents to CD4+ T helper cells, expressed only on professional APCs). Swapping these in a question is a reliable distractor.
- Stating that IgG is the first antibody produced in the primary response. IgM is first; IgG arrives after class switching.
- Forgetting that the secondary response requires re-exposure to the same antigen. A novel antigen, even in a previously immunocompetent individual, will always trigger a primary response.
- Underestimating the clinical importance of the two-signal model; anergy (not apoptosis) is the consequence of signal one alone, and this distinction is tested.
- Mixing up passive immunity (transfer of pre-formed antibody, e.g. anti-D immunoglobulin, tetanus immunoglobulin) with active immunity (generating one’s own response). Both may appear in scenario-based MRCEM SBA questions.
- Failing to link serum tryptase measurement to anaphylaxis confirmation, or not knowing the correct sampling window.
How EM Learning Centre Supports Your MRCEM Primary Revision
MRCEM Primary revision demands a structured, high-yield approach to a broad basic sciences syllabus. At the EM Learning Centre homepage, our MRCEM Primary course provides detailed lesson content across anatomy, physiology, pathology, pharmacology, and microbiology, mapped directly to the RCEM curriculum. Our immunology lessons place mechanisms such as the primary and secondary immune responses in their clinical ED context, so you are not memorising isolated facts but building the integrated understanding the exam rewards.
Our question bank includes MRCEM Primary practice questions written at examination standard, with detailed explanations that identify why distractors are wrong, not just why the correct answer is right. This approach builds the discriminatory thinking the SBA format demands. Whether you are beginning your revision or consolidating in the final weeks before your exam, the MRCEM Primary revision course at EM Learning Centre provides the structured, evidence-based support you need to pass confidently.
References
- Royal College of Emergency Medicine. MRCEM Curriculum and Syllabus. rcem.ac.uk
- Resuscitation Council UK. Emergency treatment of anaphylaxis: guidelines for healthcare providers. resus.org.uk
- National Institute for Health and Care Excellence. Immunisation guidance and clinical knowledge summaries. nice.org.uk
- NHS. The NHS childhood immunisation schedule. nhs.uk
- The BMJ. Clinical reviews in immunology and allergy. bmj.com
